UNFPA
13th Invitation to Manufacturers to Submit an Expression of Interest (EOI) for Product Evaluation by the WHO Expert Review Panel (ERP) for Reproductive Health Medicines. Request for EOI

Reference: UNFPA/DNK/EOI/17/032
Beneficiary countries: Multiple destinations (see 'Countries' tab below)
Published on: 12-Oct-2017
Deadline on: 31-Oct-2017 17:00 (GMT 2.00)

Description

13th Invitation to Manufacturers to Submit an Expression of Interest (EOI) for Product Evaluation by the WHO Expert Review Panel (ERP) for Reproductive Health Medicines.

The ERP/RHM is an independent technical body composed of external technical experts and hosted by the Unit of Regulation of Medicines and other Health Technologies (RHT) of WHO Department of Essential Medicines and Health Products (WHO/EMP/RHT). The Procurement Services Branch of UNFPA (UNFPA/PSB) provides the Secretariat for the ERP/RHM. The ERP/RHM will be convened by WHO/EMP/RHT and review product dossiers submitted by manufacturers of FPPs that are not yet WHO-prequalified or SRA-authorized, undertake a quality risk analysis associated with the use of those products and provide written advice to the Secretariat to help making evidence based procurement decisions.

Product of interest: 

  • Benzathine benzylpenicillin 2.4 million units per dose in vial for reconstitution and intramuscular Injection.

All submissions must reach the UNFPA reception in Copenhagen by Tuesday, 31 October 2017, at 17.00h (Copenhagen time).